mitomycin medac 1 mg/ml i.vesic./inj./inf. sol. (pwdr.) i.v. vial
medac gmbh - mitomycin 2 mg - powder for intravesical solution/solution for injection/infusion - 1 mg/ml - mitomycin 40 mg - mitomycin
mitomycin medac 40 mg i.vesic. sol. (pwdr. + solv.) vial
medac gmbh - mitomycin 40 mg - powder and solvent for intravesical solution - 40 mg - mitomycin 40 mg - mitomycin
mitomycin medac 20 mg i.vesic. sol. (pwdr. + solv.) vial
medac gmbh - mitomycin 20 mg - powder and solvent for intravesical solution - 20 mg - mitomycin 20 mg/ml - mitomycin
mitomycin for injection powder for solution
teva canada limited - mitomycin - powder for solution - 5mg - mitomycin 5mg - antineoplastic agents
mitomycin for injection powder for solution
teva canada limited - mitomycin - powder for solution - 20mg - mitomycin 20mg - antineoplastic agents
mitomycin for injection usp powder for solution
accord healthcare inc - mitomycin - powder for solution - 20mg - mitomycin 20mg - antineoplastic agents
mitomycin for injection, usp powder for solution
hikma canada limited - mitomycin - powder for solution - 20mg - mitomycin 20mg
mitomycin for injection usp powder for solution
pfizer canada ulc - mitomycin - powder for solution - 20mg - mitomycin 20mg - antineoplastic agents
mitomycin for injection usp powder for solution
pfizer canada ulc - mitomycin - powder for solution - 5mg - mitomycin 5mg - antineoplastic agents
mitomycin accord mitomycin powder for injection 20mg vial
omegapharm - mitomycin, quantity: 20 mg - injection, powder for - excipient ingredients: mannitol - mitomycin is indicated in the palliative treatment of carcinoma of the stomach, pancreas, colon, lung (non-small cell), breast, cervix, head and neck, liver and bladder.